Why the study?
Malonyl ginsenosides play a crucial role in treating T2DM, but their potential mechanisms remained unclear.
Does malonyl ginsenoside from Panax ginseng improve glucose-lipid metabolism and insulin resistance in diabetic mice?
Population
High fat diet-fed and streptozotocin-induced diabetic mice
Comparison
PG-MGR treatment
Design
Animal experimental study
Loading...
Supports preclinical PG-MGR investigation in T2DM; leaves open human translation.
Does malonyl ginsenoside from Panax ginseng improve glucose-lipid metabolism and insulin resistance in diabetic mice?
PG-MGR demonstrates potential to improve glucose and lipid metabolism and insulin resistance in a diabetic mouse model via IRS-1/PI3K/AKT and AMPK signaling pathways.
A 2022 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: